Barry M Weichman

Title: The Innovative Contributions of Barry M Weichman

Introduction

Barry M Weichman is a notable inventor based in Skillman, NJ (US), recognized for his significant contributions to medical science through his innovative patents. With a total of three patents to his name, Weichman has focused on developing methods to treat pulmonary inflammation and related diseases.

Latest Patents

Weichman's latest patents include a groundbreaking method of treating pulmonary inflammation. This invention provides a method of preventing or reversing pulmonary inflammation in a mammal by administering an effective amount of rapamycin orally, parenterally, intranasally, or intrabronchially. As such, rapamycin is useful in providing symptomatic relief for diseases where pulmonary inflammation is a component, such as asthma, chronic obstructive pulmonary disease, emphysema, acute respiratory distress syndrome, and bronchitis. Another significant patent involves imidazolylthioalkenoic acids and -alkenols, which have been identified as leukotriene antagonists. These compounds are useful in treating diseases where leukotrienes play a role, particularly asthma.

Career Highlights

Throughout his career, Barry M Weichman has worked with prominent companies, including SmithKline Beckman Corporation and American Home Products Corporation. His experience in these organizations has contributed to his expertise in the field of medical inventions.

Collaborations

Weichman has collaborated with notable individuals in his field, including Robert J Sturm and Laurel M Adams. These collaborations have likely enriched his work and led to further advancements in his research.

Conclusion

Barry M Weichman stands out as an influential inventor whose work has the potential to improve the lives of many suffering from pulmonary diseases. His innovative patents reflect a commitment to advancing medical science and enhancing treatment options.